Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 9, 2006The Journal of Pathology

Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNL SiebenGRGMJM RoemenJOJan OostingLeiden University Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sieben et al. (2006) studied this question.

synapsesocial.com/papers/6aae0d98322a2d038800ef35https://doi.org/10.1002/path.2074
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In ovarian neoplasms, BRAF , but not KRAS , mutations are restricted to low‐grade serous tumours2004 · 240 citations
  2. 2Serous Borderline Tumors of the Ovary2002 · 286 citations
  3. 3Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma2003 · 865 citations
  4. 4Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure2005 · 88 citations